The Clinical Safety, Pharmacokinetics, and LDL-Cholesterol Lowering Efficacy of MK-0616, an Oral PCSK9 Inhibitor
Douglas G. Johns, Yuddy Almonte,An Bautmans,Louis-Charles Campeau,Mark T. Cancilla, Justin Chapman, Inne Crevecoeur,Erik D. Guetschow,Eunkyung A. Kauh, Eseng Lai, Christine L. Lanning,Anita Y. Lee,Li Li,Yale B. Mitchel,S. Aubrey Stoch,Kristien Van Dyck,Frederic P. Vanhoutte,Bram Volckaert,Dennis G. Wolford,Harold B. Wood, Andy Xu,Tian Zhao,Susan Zhou,Puja Banka CIRCULATION（2021）
关键词
PCSK9, Atherosclerosis, LDL, Cholesterol-lowering drugs, Clinical trials
AI 理解论文
溯源树
样例
